Pharma tech spend shows greater focus on 'here and now' tools during pandemic

11 November 2020
digital-pharma-large-1-

COVID-19 has led pharma companies to rethink their operations and customer access, says GlobalData research.

GlobalData’s latest report, Digital Transformation and Emerging Technology in the Healthcare Industry – 2020, reveals that social media and cloud computing became the leading technologies for current investments for pharma in 2020, with respectively 60% and 56% pharmaceutical industry professionals confirming this trend.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical